Office of the Chief Scientist of Israel - OCS

Office of the Chief Scientist of Israel - OCS

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Israel, Tel Aviv


The main office of this Corporate Investor is situated in Tel Aviv. This investor is located in Asia, Israel.

The fund typically invests in rounds with 1-2 participants. Besides Office of the Chief Scientist of Israel - OCS, start-ups are typically funded by Sirius Venture Capital Pte Ltd, SLJ Investment Partners, Global Life Science Ventures. Other VCs who often invest in the same rounds are Maayan Ventures, hiCenter Ventures, Oriella PR Network. The investors in the following rounds are usually Oriella PR Network, EASME - EU Executive Agency for SMEs, 500 Startups.

In comparison with other funds, Office of the Chief Scientist of Israel - OCS makes 18 percentage points less than the average number of lead investments. We recorded the biggest number of exits for this fund in 2018. The fund's activity peaked in 2013. Additionally, in 2019 the fund was active. In real terms, this Corporate Investor performs 9 percentage points less exits than other funds. The fund typically enters into less than 2 deals annually. The most common rounds for this fund are in the range of 100 thousands - 1 million dollars.

The country of its foundation and the country of its most frequent investments coincides - Israel. Besides this, the fund also invested in 1 other country. Hargol FoodTech, Cell Cure Neurosciences, User1st are amongst the various portfolio companies of this fund. Moreover, a start-up needs to be 2-3 years old to get investment from this fund. The fund has no an exact preference in the amount of founders of companies in its portfolio. When a start-up has 4 or 5+ founders, the probability of closing the deal is low. We can highlight the most popular investment areas for this fund, such as AgTech, Medical. In addition, there are 8 more industries where it has achieved success.

Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name:; User name format in descending order of probability: first last_initial, last first_initial, first last, first, first_initial last

Group Appearance [how often fund is operating separately from groups with shared interest]

87.5% of cases

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

5.6% of cases

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

4 years

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: